.jpg)
.png)
All
Hello NLA members, I hope everyone had a wonderful summer. As our long, warm days move into cool fall nights, the NLA continues to charge ahead, expanding educational opportunities for providers to combat the rise of cardiovascular disease. The fall CLU in Scottsdale, Arizona, will go... more
Results from multiple trials prompted the Food and Drug Administration’s (FDA) approval of empagliflozin (Jardiance) for reducing cardiovascular (CV) death and canagliflozin (Invokana) for reducing CV death and CV events, in patients with cardiovascular disease and type II diabetes (T2D).(1-6) The... more
The Very High ASCVD Risk Category Atherosclerotic cardiovascular disease (ASCVD) risk assessment has long been simplified to only several major risk factors and only a few categories, ranging from low to very high, despite the spectrum and magnitudes of risk factors and striking cumulative... more
MEMBERS ONLY: As a member of the NLA, your expertise and knowledge of dyslipidemia is a valued opinion for a pediatric dyslipidemia survey. Please log in and follow the links to the questionnaire.
Highlights from the NLA's Fall 2013 Clinical Lipid Update are now available on demand. You can now view selected presentations with audio from the sessions. Click here to view the highlights.
The Foundation of the National Lipid Association (NLA) is constantly searching for new ways to reach members and educate the public about cholesterol disorders. And we’re always encouraged by the support we receive. This year we are excited to welcome a new member to the Foundation Board of... more
ka·lei·do·scope | \ kə-ˈlī-də-ˌskōp \ Definition of ‘kaleidoscope’ The name is derived from the Greek words kalos (“beautiful”), eïdos (“form”), and skopeïn (“to view”). 1. an instrument containing loose bits of colored material (such as glass or plastic) between two flat... more
.color-blue{ color: #23527c; } Atherosclerotic cardiovascular disease (ASCVD) is a major cause of death and disability worldwide. More than 80% of the global burden of ASCVD occurs in low- and middle-income countries.(1) As a means of attenuating this global epidemic, the concept of... more
.page-header { display:none; } Committees and Councils The National Lipid Association offers the following committees as an excellent way to get involved. Participation is completely voluntary. The Committees listed in this section are managed by the Board of Directors. For more... more
With the rising prevalence of obesity among minority youth in the United States (US),(1,2) there has been a concurrent rise in associated comorbidities such as youth-onset diabetes and hypertension.(3-6) American Indian/Alaska Native (AI/AN) youth are at high risk for obesity that is a predictor of... more